Caisse de Depot et Placement du Quebec (CDPQ)
NKTR icon

Caisse de Depot et Placement du Quebec (CDPQ)’s Nektar Therapeutics NKTR Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-513
Closed -$274K – 842
2019
Q2 		$274K Buy
+513
New +$257K ﹤0.01% 751
2018
Q4 		– Sell
-4,227
Closed -$3.87M – 758
2018
Q3 		$3.87M Buy
+4,227
New +$3.61M 0.01% 388

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s NKTR Position: Q3 2019 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 513 shares — an estimated $274K sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in NKTR in Q3 2018 and held it in 2 quarters. The position peaked at $3.87M in Q3 2018. 288 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 513 Nektar Therapeutics shares in Q3 2019, an estimated $274K.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Nektar Therapeutics in Q3 2018 and held it in 2 quarters.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s Nektar Therapeutics position peaked at $3.87M in Q3 2018.
  • 288 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q3 2019, filed 14 Nov 2019.